Photoimmunotherapy: A New Precision Targeted Approach to Treat Cancer.

Photoimmunotherapy is based on a new drug system that consist of a cancer targeting monoclonal antibody conjugated to a photoactivatable molecule. This drug conjugate is not pharmacologically active until the conjugate is bound to the cancer cells and gains anticancer activity upon light-mediated activation at the tumor site. Tumor targeting and context precision activation of the drug provides exquisite cancer specificity and permits rapid cancer cell killing without damage to the surrounding healthy tissues.

Anticancer activity of Photoimmunotherapy is highly effective and it works with multiple types of monoclonal antibodies, thus the platform enables the targeting of a broad range of cancer antigens and tumor types.